Research & Invest
Investor, Institutional Asset Management Background
ACM Research carries binary China risk: China is about 97% of its business, and authorities could stop it any day, forcing management to choose between San Jose and China. The CCP's threats toward other countries make that exposure uglier, whatever the company's $4B revenue ambition. x.com x.com x.comÂ
ACM Research looked great as a value stock, but less so once it is clear it only makes wafer-cleaning equipment. @masayoshisson sees it, like nearly every AI stock, showing textbook complacency before complete capitulation, perhaps a few months after an Anthropic IPO. x.comÂ
China-heavy emerging-market funds carry a lasting governance risk: autocratic leadership has little alignment with foreign shareholders. Chinese shares may offer tactical trades, but a permanent rerating is hard until the CCP is gone. x.com x.com x.comÂ
ACM Research is the best idea under $5B in market cap right now because China is going to keep pushing for localization. Ongoing dilution of its stake in its Shanghai subsidiary is a valid concern, but a necessary one. x.com x.comÂ
Webull faces a national-security overhang from its China ties. Per CNBC, citing House congressional panel findings, Webull's China ties are a national security risk, and the stock dropped 10%. The core problem is that Webull controls $25B of customer assets and allegedly routes retail data through a mainland development team. The CEO has sold 200k shares since late August, and other insiders have also been selling. x.com x.comÂ
AXT's indium phosphide business is at China's mercy, since its expansion inside China lets Beijing decide every line item on every purchase order. Per a report shared by @wallstengine, US officials are pressing China over delayed InP export approvals as the material becomes an AI data center bottleneck, and AXT says export permits are its biggest challenge. The stock was rejected at resistance despite that news. x.com x.com x.comÂ
ACM Research looks underpriced because its Chinese subsidiary alone has a backlog equal to about half the company's market cap. ACM Shanghai's backlog rose 88.2% to $2.5B, yet the stock barely reacted. x.com x.comÂ
Chinese stocks are uninvestable for long-term investors because the value created goes to the Communist Party, not shareholders. The Chinese index is down 16% since 1991 while the S&P 500 rose 1,570% and the Nasdaq 3,440%, and Alibaba has gained just 27.8% in 12 years since its IPO. When companies grow too strong, the party hits them with megafines, sidelines founders like Jack Ma or blocks game releases as at Tencent, and foreign investors own only VIE contracts, not shares. x.com x.com x.com … Show more
KLA's post-earnings selloffs are unjustified: its China issue is well known, and the company has disclosed no substantial change, positive or negative. Unless something highly damaging is announced, gaps down are buying opportunities, with shares nearing an all-time high. After its second-quarter report, KeyBanc saw a modest beat and a slightly above-consensus outlook, while Evercore ISI said supply-driven lead times may cap first-half upside. x.comÂ
ACM Research should benefit as China's wafer fab equipment spending soars over the next couple of years across memory and leading-edge logic, more than offsetting lower mature-node spending. Its advanced packaging sales to non-Chinese clients are also growing well, and valuation looks reasonable after the recent pullback. x.comÂ
TSMC belongs in every portfolio because its growth, moat, market dominance and pricing power are unmatched, and ignoring it over China risk is a mistake. It holds about 90% of the advanced-node market, and the AI buildout keeps pulling demand toward the chips it makes best. Even assuming growth slows to 14%, gross margin eases to 63.5% and a 25x exit multiple, the stock reaches $937 by 2031, a 17.75% annual return. Risks include China, rising capex, customer concentration and hyperscaler cuts. … Show more
